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A B S T R A C T
Background: During 2008, Singapore experienced its largest ever outbreak of hand, foot and mouth
disease (HFMD), resulting in 29 686 cases, including four cases of encephalitis and one fatality.
Methods: A total of 51 clinical specimens from 43 patients with suspected HFMD at the National
University Hospital, Singapore were collected for virus isolation and identiﬁcation by reverse
transcription polymerase chain reaction (RT-PCR) and sequencing.
Results: Enteroviruses were identiﬁed in 34 samples (66.7%), with 11 samples (21.6%) being positive for
enterovirus 71 (EV71). Other non-EV71 enteroviruses (including coxsackievirus A4, A6, A10, and A16)
were identiﬁed in 23 samples (45.1%). The most prevalent virus serotypes were CA6, CA10, and EV71.
CA6 and CA10 accounted for 35.3% of all HFMD cases, which may explain the high transmissibility and
low fatality that characterized this unprecedented epidemic associated with relatively mild disease.
Phylogenetic analyses of 10 circulating EV71 strains indicated that they belonged to two subgenogroups,
i.e., B5 (80%) and C2 (20%). The VP1 sequences of the 2008 EV71 strains also exhibited continuous
mutations during the outbreak, reﬂecting the relatively high mutation rate of the EV71 capsid protein,
which may have implications for future vaccine development.
Conclusions: A safe and effective vaccine against EV71 is certainly warranted in view of its potential
neurovirulence and its role in HFMD epidemics of recurring frequency with resultant fatalities in Asia, as
well as other parts of the world.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Hand, foot and mouth disease (HFMD) is a common childhood
disease characterized by a brief febrile illness, typical vesicular
rashes on the palms, soles, or buttocks, and oropharyngeal ulcers.
In rare cases, patients may also develop neurological complica-
tions, such as encephalomyelitis, aseptic meningitis, and acute
ﬂaccid paralysis.1,2 The most common etiologic agents are
coxsackievirus A16 (CA16) and enterovirus type 71 (EV71).
However, throughout an outbreak, many other enteroviruses,
such as coxsackieviruses A4 and A6 and certain echoviruses, may
co-circulate. EV71 has been strongly associated with neurological
complications, especially during large HFMD epidemics triggered
by EV71 within the Southeast and East Asian regions in recent
times.3
In 2008, the largest outbreak of HFMD in Singapore afﬂicted
29 686 patients ranging from kindergarten to primary school* Corresponding author. Tel.: +65 65163691; fax: +65 67766872.
E-mail address: micctk@nus.edu.sg (Vincent T.K. Chow).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.07.006students, four of whom developed EV71-related encephalitis.
Moreover, a 3-year-old boy with EV71 infection died of encepha-
lomyelitis in August 2008 – the ﬁrst HFMD-related death since
2001.4 Although the HFMD cases surged to an unprecedented high
level, only a single fatality was documented, suggesting that the
strains responsible for the 2008 Singapore outbreak caused highly
transmissible but relatively mild disease.
In this study, clinical samples from HFMD patients were
investigated in order to identify the circulating virus serotypes in
the 2008 HFMD outbreak in Singapore. The predominant
enteroviruses and EV71 subgenogroups were characterized by
phylogenetic and genome sequence analyses.
2. Materials and methods
2.1. Patients, clinical specimens, virus isolation, and statistical tests
This study was approved by the Institutional Review Board of
the National University of Singapore (Approval No. NUS-301).
Between March 13 and August 15, 2008, clinical samples were
obtained from 43 children presenting with suspected HFMD at theses. Published by Elsevier Ltd. All rights reserved.
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Figure 1. Distribution of clinical features in EV71 and non-EV71 patients.
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criteria were the presence of papules and/or ulcers on the palms,
soles, or buttocks or in the mouth. A similar HFMD case deﬁnition
was used in a previous study of the HFMD outbreak in 2000.4 A
total of 51 samples, including throat swabs, nasal swabs, rectal
swabs, saliva, urine, and blood were collected. Throat, nasal, and
rectal swabs were transferred into virus transport medium. For
virus isolation, all specimens were immediately inoculated upon
receipt into the human rhabdomyosarcoma (RD) cell line, and
cultured for up to three passages.5,6 Pathogens other than
enteroviruses were not investigated. The statistical differences
between proportions were tested using the Chi-square test or
Fisher’s exact test.
2.2. RNA extraction and reverse transcription
Viral RNA was extracted using the QIAamp viral RNA mini kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. Reverse transcription (RT) was performed to synthe-
size cDNA using MMLV (Moloney murine leukemia virus) reverse
transcriptase.7
2.3. EV71 real-time RT-PCR hybridization assay
Each specimen was subjected to a real-time one-step RT-PCR
hybridization assay with EV71-speciﬁc primers and probes FL and
LC using the LightCycler RNA ampliﬁcation hybridization probe kit
(Roche Applied Science, Indianapolis, IN, USA), as reported
previously.7
2.4. Classical RT-PCR and direct sequencing for enterovirus
identiﬁcation
Several pairs of primers were employed for the identiﬁcation of
enteroviruses. Firstly, pan-enterovirus (pan-EV) primers were used
for enterovirus detection by amplifying a target within the 50
untranslated region (50UTR).8 To conﬁrm the enterovirus type,
50UTR-F and 50UTR-R primers were employed to amplify a segment
also within the 50UTR of all enteroviruses,9 and ampliﬁed products
were subjected todirectDNAsequencing. ForEV71detection,VP3-Fa
and EV2A-R primers targeting the VP1 gene of all EV71 genogroups
(50-ATWWTRGCAYTRGCGGCRGCC-30 and 50-TCGCKRGAGCTGT
CTTCCCAVA-30, respectively) were newly designed to amplify a
1200-bp segment, followed by DNA sequencing. To conﬁrm the
identity of non-EV71 enteroviruses, primers were designed to
amplify the 30 segment of VP110 for CA4 (50-CCTAAGCCTGATGCCC-
GAGA-30 and 50-TTGTGATCTCAAAGGCCTAGGGA-30), CA6 (50-
GTGTCCGTCCCATTCATGTC-30 and 50-GTTCTCTGTGGGTCTGCTGG-
30), CA10 (50-AAACCGACTGGAAGGGATGC-30 and 50-CGATCTCGTG-
CACTGTTGGC-30), and CA16 (50-TGAAAATGACGGACCCACCA-30 and
50-ATCTTGTCTCTACTAGTGCTGGTG-30).
2.5. DNA sequencing, nucleotide and amino acid sequences, and
phylogenetic analyses
All amplicons were sequenced in both directions using the
BigDye cycle sequencing kit and ABI automated DNA sequence
analyzer (Applied Biosystems, Carlsbad, CA, USA). Sequences were
subjected to BLAST analysis (www.ncbi.nlm.nih.gov/blast), while
ClustalW (www.ebi.ac.uk/tools/clustalW2/index.html) was ap-
plied for multiple sequence alignment.11 A phylogenetic tree
was constructed based on EV71 VP1 nucleotide sequences of 10
Singapore 2008 strains togetherwith selected strains isolated from
different geographic regions from 1974 to 2003 that were used to
construct the tripartite genogroup structure of EV71.12 In addition,
two strains from fatal cases of the 2000 Singapore outbreak and2008 China outbreak were selected for comparative sequence
analysis. The dendrogramwas constructed by the neighbor-joining
method using MEGA 4.0 software, and bootstrapping was
performed from 1000 replicates.
3. Results
3.1. Clinical features of patients with EV71 versus non-EV71 infections
Clinical data were available for 42 out of 43 patients; most of
them (n = 37, 88.1%) received outpatient treatment at the
Children’s Emergency Department, while only 12.0% (n = 5) were
hospitalized on the pediatric ward. The number of females and
maleswas similar, and themajority of patients (n = 28, 66.7%)were
under 5 years of age. With regard to age group, the highest
percentages of patients were children aged 3 years (40% of EV71
and 19% of non-EV71) and 4 years (20% of EV71 and 22% of non-
EV71).
Figure 1 compares the symptoms of HFMD patients infected
with EV71 and other enteroviruses. None of the patients presented
with severe symptoms, and there were no fatal or encephalitis
cases. Notably, papules were observed for all cases, while mouth
ulcers were also seen in almost all cases, i.e., 90% (n = 10) for EV71
versus 100% (n = 32) for non-EV71 infections. Papules and mouth
ulcers are two of the clinical criteria for the diagnosis of HFMD and
herpangina. Interestingly, more than ﬁve papular lesions per
patient were noticed in 75% (n = 9) of those positive for EV71 and
CA16, compared to only 43% (n = 13) of other patients, but this was
not statistically signiﬁcant (p > 0.05). Rhinorrhea was only
observed in 31% (n = 10) of non-EV71 infections and not in any
EV71 infections. Poor feeding was documented in 30% (n = 3) of
EV71 cases and in 25% (n = 8) of non-EV71 infections. With regard
to other clinical signs, non-EV71 patients displayed these more
frequently, but the differences were not statistically signiﬁcant
(p > 0.05). For example, the difference was about two-fold for
cough and vomiting, while diarrhea was only occasionally
observed.
3.2. Pan-enterovirus RT-PCR, direct sequencing, and virus isolation
elucidate the distribution of enterovirus types and the involvement of
EV71 in HFMD patients
Only one clinical sample was collected from each of 37 patients,
while three different clinical samples were collected from two
patients and two from four patients, giving a total of 51 samples
from 43 patients. Table 1 summarizes the detection rate based on
clinical sample type, and highlights the throat swab as a good
clinical specimen for HFMD virus detection and isolation. This
Table 1
Identiﬁcation of enteroviruses by classical and real-time RT-PCR and virus isolation from different clinical specimens.
Virus detection
technique
Throat swab
(n=38)
Saliva
(n=3)
Nasal swab
(n=1)
Rectal swab
(n=3)
Urine
(n=3)
Foot ulcer
(n=1)
Blood
(n=2)
Overall positivity
rate (%)
Pan-EV 154bp 26 3 0 2 2 1 0 66.7
Pan-EV 439bp 26 3 0 2 2 1 0 66.7
VP3-Fa and EV2A-R 8 2 0 0 1 0 0 21.6
Real-time RT-PCR 0 0 0 0 0 0 0 0
Virus isolation 17 0 0 2 0 0 0 37.2
RT-PCR, reverse transcription polymerase chain reaction.
Table 2
Distribution of enteroviruses identiﬁed in clinical specimens.
Enterovirus serotype Number of cases Percentage (%)
CA4 3 5.9
CA6 12 23.5
CA10 6 11.8
CA16 2 3.9
EV71 11 21.6
EV-negative 17 33.3
Total 51 100
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expected in patientswithmultiple vesicles and/or ulcers in the oral
mucosa. We did not collect vesicular ﬂuid samples from our
patients as their parents perceived this procedure to be invasive
and painful.
Classical RT-PCR assays with both pairs of pan-EV primers
targeting the 50UTR were able to detect enteroviruses in 34
samples (66.7%), with 17 samples (33.3%) being enterovirus-
negative (Table 2). RT-PCR with EV71-speciﬁc primers VP3-Fa and
EV2A-R detected 11 EV71-positive samples (21.6%). In addition,
the non-EV71 enterovirus types were identiﬁed via sequencing of
50UTR and VP1 amplicons. The circulating enteroviruses responsi-
ble for the 2008 Singapore outbreak included CA4, CA6, CA10,
CA16, and EV71, the most prevalent being CA6 (23.5%), EV71
(21.6%), and CA10 (11.8%). It is noteworthy that CA4 and CA16
accounted for only 9.8%, even though CA16 has played amajor role
in previous HFMD outbreaks. If the enterovirus-negative samples
were excluded,more than 50% of the sampleswere positive for CA6
and CA10, while 32% were EV71-positive, thus reiterating the
predominant role of CA6, CA10, and EV71 in this outbreak. Thiswas
corroborated by cell culture inoculation, which successfully
isolated enteroviruses from 19 out of 51 samples (approximately
40%), later conﬁrmed as nine CA6 (47.4%), six CA10 (31.6%), three
EV71 (15.8%), and one CA4 (5.3%).
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Figure 2. Sequence alignment of 10 outbreak EV71 strains against the hybridization
acceptor probe for real-time RT-PCR. The highlighted mismatches may explain the
failure of detection of the EV71 strains using this assay. The subgenogroups of the
strains, and nucleotide positions at the 50 (2496) and 30 (2519) ends of the probe are
shown.The EV71 real-time RT-PCR hybridization assay failed to detect
EV71 in all 51 specimens. VP1 sequence alignment of the 10 EV71
strains with the RT-PCR primers and hybridization probes revealed
one mismatch in each primer. However, three mismatches were
found for the probe with acceptor ﬂuorophore spanning nucleo-
tides 2519–2496, one of which was near the 30 end (Figure 2) and
may compromise binding of the probe to the target product
leading to failure of detection. This mismatch of the latter probe
rather than primers was supported by classical RT-PCR using the
primers which could amplify speciﬁc bands for all EV71 strains as
detected by gel electrophoresis (data not shown).
3.3. Molecular epidemiology of EV71 outbreak strains identiﬁes two
major subgenogroups
Out of the 11 EV71-positive samples, 2 were from the same
patient, with the rest from individual patients. Thus, the
distribution of EV71 subgenogroups of 10 strains was determined
by RT-PCR ampliﬁcation of their complete VP1 fragments, followed
by nucleotide sequencing and phylogenetic analyses. The sub-
lineage structure of EV71 was reconstructed,12 and revealed two
circulating subgenogroups (Figure 3) belonging to B5 (eight strains
or 80%) and C2 (two strains or 20%). Three EV71 strains were
successfully isolated from the samples, two of which were B5 and
the other was C2. Interestingly, the VP1 sequences of strains from
the dominant B5 subgenogroup displayed differences, whereas
those of the two subgenogroup C2 strains were identical. The
complete viral genomes of the two representative subgenogroups
B5 (NUH0083/SIN/08) and C2 (NUH0075/SIN/08) were sequenced
and deposited in the GenBank database under accession numbers
FJ461781 and EU868611, respectively. The GenBank accession
numbers for the other sequences are FJ461782–FJ461789 and
GU198753–GU198764.
3.4. VP1 sequence comparison reveals interesting disparities between
2008 outbreak and known virulent strains
Twelve VP1 gene sequence disparities of B5 strains were
identiﬁed, suggesting the occurrence of viral evolution and
mutation during this outbreak (Figure 4). An interesting trend
was noticed at nucleotides 19, 373, and 756, whereby three B5
samples obtained in April and May 2008 (NUH0049, 0047, 0086)
were identical at these positions, in contrast to the existence of
disparities for the other ﬁve B5 strains that were received later,
during mid-May to August 2008 (NUH0083, 0085, 0043, 0037,
0012). Furthermore, two B5 strains that were collected later
harbored non-conservative VP1 amino acid substitutions, i.e., K to
E at position 215 of NUH0043, and T to A at position 289 of
NUH0037. These phenomena provide strong evidence for virus
mutational events through the course of the outbreak that may
partly arise from strong immunological pressure on the immuno-
dominant VP1 region. In addition, for the 2008 strains, disparities
were discovered at three VP1 epitopes that are capable of eliciting
neutralizing antibodies against EV71 in vitro and in vivo.13–15
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Figure 3.Dendrogram constructed based on the complete VP1 gene sequences of 10 outbreak EV71 strains and selected known strains, elucidating B5 and C2 as the respective
major andminor EV71 subgenogroups circulating during the 2008 Singapore epidemic. The percentages of replicate trees in which the associated taxa are clustered together
are shown next to the branches. Branch lengths are proportional to the number of nucleotide differences.
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polar amino acid change within the SP55 peptide. Therefore, the
neutralizing antibodies of patients infected with previous EV71
strains may not be able to recognize the 2008 counterpart strains.In 2008, EV71 epidemics were documented in many other
countries in East Asia, but the behavior of the causative strains
varied somewhat. For example, the predominant strain in the 2008
China and Vietnam epidemics belonged to subgenogroup C4,16 and
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EV71 B5 strain
Collecon
date
(2008) 7 19 373 427 439 604 644 658 756 820 832 866
NUH0049/SIN/08 7 Apr T C A T T C A T T C A A
NUH0047/SIN/08 7 Apr T C A T T C A T T C A A
NUH0086/SIN/08 6 May T C A T T C A T T C A A
NUH0083/SIN/08 15 May C T G T C T A T C C A A
NUH0085/SIN/08 3 Jun T T G C T C A C C C A A
NUH0043/SIN/08 12 Jun T T G C T C G T C C A A
NUH0037/SIN/08 14 Aug C T G T C T A T C T G G
NUH0012/SIN/08 15 Aug T T G T C T A T C C A A
Figure 4. Alignment of VP1 nucleotides of eight EV71 strains belonging to subgenogroup B5 according to the time of specimen receipt. The disparities at 12 different positions
highlight the evolution of the VP1 regions of B5 strains during the course of the large epidemic. For example, ﬁve disparities at positions 644, 658, 820, 832, and 866 emerged
in strains that were obtained later in the outbreak. Common disparities at nucleotides 19, 373, and 756 were also identiﬁed only in strains detected later.
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SP12 (34–48) VSSHRLDTG E VPALQ C
2008 strains VSSHRLDTG (K/E) VPALQ A
SP55 (163–177) P E SRESLAWQTATNP C
2008 strains P D SRESLAWQTATNP S
SP70 (208–222) YPTFGEHKQEKDLEY C
2008 strains YPTFGEHKQEKDLEY G
Figure 5. Amino acid sequence variations within the VP1 neutralizing antibody
epitopes SP12, SP55, and SP70 of the 2008 outbreak EV71 strains.
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Figure 6. Weekly incidence of hand, foot and mouth disease in Singapore during
2008 and 2009. The dotted line depicts the epidemic threshold of 665 cases
(www.moh.gov.sg/mohcorp/statisticsweeklybulletins.aspx).
Y. Wu et al. / International Journal of Infectious Diseases 14 (2010) e1076–e10811080exerted relatively high virulence culminating in numerous child
fatalities. In contrast, the B5 and C2 strains of the 2008 Singapore
outbreak caused generally mild disease. VP1 constitutes the major
capsid protein and is considered to be an important factor that
mediates viral pathogenesis.17 To better understand differences in
their VP1 amino acid composition, the 10 Singapore 2008 strains
were compared with two virulent strains from fatal cases, i.e.,
Fuyang.Anhui.PRC/17.08/3 from the 2008 China outbreak and
5865/Sin/000009 from the 2000 Singapore outbreak. A disparity at
position 22 was noted, with R being replaced by Q or H in virulent
strains, making it less basic. The Fuyang strain displayed an E to K
substitution at position 98 that could result in conformational
change at the hydrophobic pocket of VP1.18 Another mutation at
amino acid 164 of the virulent 2000 Singapore strain was
identiﬁed, but this was a conservative substitution.
4. Discussion
HFMD has been a legally notiﬁable communicable disease in
Singapore since October 1, 2000, and the capture of epidemiologic
data on HFMD has been effective since then. The 2008 outbreak
represents the largest HFMD epidemic in Singapore since the year
2000, with almost 30 000 cases, four patients with encephalitis,
and one fatality. However, the actual number of HFMD cases may
have been much higher given that most infections are asymptom-
atic. There were two periods within which the number of infected
cases increased signiﬁcantly above the epidemic threshold, i.e., a
large peak from mid-March to the end of May (10 927 cases in
weeks 12–22), and a smaller peak from early October to early
December 2008 (5391 cases in weeks 42–49). However, in 2009,
the number of HFMD cases did not exceed the epidemic threshold,
and 17 278 cases were reported in 2009 (without any encephalitis
cases or deaths), compared with 29 686 for the whole of 2008
(Figure 6).
The specimens in our cohort were collected from patients with
mild disease andwithout complications or sequelae, of whom only12% were hospitalized. Despite the relatively small sample size,
this cohort is a subset representative of the pediatric HFMD cases
in the community during the 2008 Singapore outbreak, as the
specimenswere obtained during and after the peak of the epidemic
curve based on distinct recruitment criteria. The most prevalent
enterovirus infections associated with the 2008 Singapore
outbreak were attributed to CA6, followed by EV71 and CA10.
Both CA6 and CA10 are common etiologic agents of herpangina and
have been prevalent in Japan since 2005,19,20 and are less virulent
but apparently more infectious than EV71. Consequently, the high
transmissibility of HFMD during the 2008 Singapore epidemicmay
be due to the dominance of CA6 and CA10. In the autumn of 2008 in
Finland, CA6 and CA10 were also reported to be the predominant
enteroviruses causing a large outbreak of HFMDwith onychomad-
esis.21,22
The similar clinical presentations of HFMD and herpangina
make it difﬁcult for physicians to accurately diagnose the two
disease entities. Most patients infected by non-EV71 and non-
CA16 enteroviruses presented fewer than ﬁve papules, whereas
the signiﬁcant majority of EV71 and CA16 patients exhibited more
than ﬁve papules. From a general clinical perspective, it is
suspected that patients with fewer than ﬁve papules may actually
be suffering from herpangina rather than HFMD. Hence, we
postulate that this outbreak comprised a mixture of HFMD as well
as herpangina cases. Moreover, the percentage of patients who had
fever was signiﬁcantly different between patients with EV71 and
those with non-EV71 infections.
Besides CA6 and CA10, another major contributor was EV71,
which accounted for more than one third of enterovirus-positive
cases. VP1-based phylogenetic analysis revealed two EV71
subgenogroups, namely B5 and C2. There have been two major
lineages (B and C) circulating during HFMD outbreaks in Southeast
Asia since 1997, with ﬁve subgenogroups under genogroup B. B1
and B2were identiﬁed throughout the world during the 1970s and
Y. Wu et al. / International Journal of Infectious Diseases 14 (2010) e1076–e1081 e10811980s. B3 and B4 later emerged as the dominant subgenogroups in
Australia, Malaysia, and Singapore.23–25 Subgenogroup B5was ﬁrst
identiﬁed in Japan in 2003, and replaced the previous dominant
strain within a short period of time.26 In Singapore, the transition
of the predominant EV71 subgenogroup from B4 in 200027 to B5 in
2008 correlatedwith the reduced fatality rate from7/4000 to1/
30 000. Replacement of subgenogroups was also witnessed in
Taiwan and Sarawak in 2008.28 Subgenogroup C2 was initially
identiﬁed in Taiwan, being responsible for the largest ever HFMD
outbreak in 1998. In the 2008 Singapore outbreak, C2 subge-
nogroup accounted for only one-ﬁfth of EV71-positive samples,
relegating it to a minor role. Nevertheless, this reiterates that
multiple genetic lineages of EV71 circulate endemically in the
Singapore population all year round.
The complete nucleotide sequence analyses of whole EV71
genomes facilitate the characterization of circulating strains at the
genetic level and of their predicted viral proteins. Interactions
between viruses and their hosts play critical roles in virus
evolution of structural and non-structural genes. Quite a number
of VP1 mutations were observed in the 10 studied EV71 strains in
comparison with known sequenced strains. This reﬂects the
relatively high mutation rate of EV71, which helps it to escape
human immune surveillance. The considerable mutation rate of
the EV71 capsid protein may also have implications on future
vaccine development.29 Furthermore, disparities were also dis-
covered in other non-structural and non-coding regions such as the
3D polymerase and 50UTR (data not shown). Finally, a safe and
effective vaccine against EV71 is certainly warranted in view of its
potential neurovirulence and its role in HFMD epidemics of
recurring frequency with resultant fatalities in Asia, as well as
other parts of the world.15
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